Andrew Obenshain
Vorstandsvorsitzender bei BLUEBIRD BIO, INC.
Vermögen: 255 638 $ am 30.04.2024
Aktive Positionen von Andrew Obenshain
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BLUEBIRD BIO, INC. | Direktor/Vorstandsmitglied | 04.11.2021 | - |
Vorstandsvorsitzender | 04.11.2021 | - | |
Präsident | 04.11.2021 | - | |
Corporate Officer/Principal | 01.01.2016 | 04.11.2021 | |
bluebird bio (UK) Ltd.
bluebird bio (UK) Ltd. BiotechnologyHealth Technology Founded in 2016, bluebird bio (UK) Ltd. is a British biotechnology company that engages in research and development. The company is based in Basingstoke, UK and is a subsidiary of bluebird bio, Inc. | Direktor/Vorstandsmitglied | 30.03.2017 | - |
Karriereverlauf von Andrew Obenshain
Ehemalige bekannte Positionen von Andrew Obenshain
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Shire France SAS
Shire France SAS Pharmaceuticals: MajorHealth Technology Shire France SA manufactures pharmaceutical products. The firm offers prescriptions and proprietary drugs. It specializes in therapeutic areas such as hematology, nephrology, central nervous system, gastrointestinal, and genetic diseases. The company was founded in 1997 and is headquartered in Paris, France. | Corporate Officer/Principal | - | - |
Ausbildung von Andrew Obenshain
Kellogg School of Management | Masters Business Admin |
Dartmouth College | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Vereinigtes Königreich | 2 |
Frankreich | 2 |
Operativ
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BLUEBIRD BIO, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
bluebird bio (UK) Ltd.
bluebird bio (UK) Ltd. BiotechnologyHealth Technology Founded in 2016, bluebird bio (UK) Ltd. is a British biotechnology company that engages in research and development. The company is based in Basingstoke, UK and is a subsidiary of bluebird bio, Inc. | Health Technology |
Shire France SAS
Shire France SAS Pharmaceuticals: MajorHealth Technology Shire France SA manufactures pharmaceutical products. The firm offers prescriptions and proprietary drugs. It specializes in therapeutic areas such as hematology, nephrology, central nervous system, gastrointestinal, and genetic diseases. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
- Börse
- Insiders
- Andrew Obenshain
- Erfahrung